Top Markets
#1 Galxe Galxe +87.79%
#2 Akedo Akedo +81.34%
#3 Gravity Gravity +56.29%
#4 Starknet Starknet +48.50%
#5 Bedrock Bedrock +44.79%
#6 Pearl Pearl +40.83%
#7 Railgun Railgun +38.97%
#8 TENDIES TENDIES +35.36%
#9 Pieverse Pieverse +34.15%
#10 MYX Finance MYX Finance +32.21%
Coin of the day
Galxe Galxe
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVXA
Rangering i aksjer #38483
Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc... Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc operates as a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market innovative therapies for various female sexual dysfunctions. Its primary drug candidate, BP-101, is being developed as a medical treatment for premenopausal women diagnosed with hypoactive sexual desire disorder. This compound is presently in Phase II clinical investigation in Australia and New Zealand, and has progressed to Phase III clinical trials within Russia. Beyond its core pharmaceutical work, the company also participates in mineral exploration and offers supplementary support services. The organization, originally incorporated as Ovoca Gold plc, rebranded to Ovoca Bio plc in July 2018.
Aksjekurs
$0.01142111
Sist synkronisert: 2025-03-21
Markedsverdi
$930.66K
Endring (1 dag)
0.18%
Endring (1 år)
-69.73%
Land
IE
Handel Ovoca Bio plc (OVXA)

Kategori

Healthcare
Antall utestående aksjer for Ovoca Bio plc (OVXA)
Antall utestående aksjer per June 2024: 92.84M
Ifølge Ovoca Bio plc sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 92.84M. Ved slutten av December 2023 hadde selskapet 75.11M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Ovoca Bio plc (OVXA) fra 2001 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 92.84M -99.55%
2024 20.72B 27,488.06%
2023 75.11M -7.91%
2022 81.56M 0.00%
2021 81.56M 0.00%
2020 81.56M 0.00%
2019 81.56M 0.00%
2018 81.56M 0.00%
2017 81.56M 0.00%
2016 81.56M 0.00%
2015 81.56M -6.64%
2014 87.36M 0.00%
2013 87.36M 0.00%
2012 87.36M -0.61%
2011 87.90M -0.64%
2010 88.46M 0.00%
2009 88.46M 1.33%
2008 87.30M 28.36%
2007 68.01M 45.51%
2006 46.74M 129.03%
2005 20.41M 194.39%
2004 6.93M 19.17%
2003 5.82M 1.55%
2002 5.73M 3.94%
2001 5.51M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 173.50%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -33.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 326.56%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 415.87%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH